Clinical Trial Update: An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 exploratory clinical trial is investigating CD19 CAR NK cells for antisynthetase syndrome and rheumatoid arthritis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antisynthetase Syndrome
• Rheumatoid Arthritis

Drugs mentioned

• CD19 CAR NK cells (CD19 CAR NK cell therapy)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Antisynthetase Syndrome, Rheumatoid Arthritis | EARLY_Phase 1 | Status: RECRUITING